A detailed history of Morningstar Investment Services LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Morningstar Investment Services LLC holds 1,040 shares of VRTX stock, worth $425,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,040
Previous 1,029 1.07%
Holding current value
$425,110
Previous $486,000 1.03%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$460.0 - $505.78 $5,060 - $5,563
11 Added 1.07%
1,040 $481,000
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $148,874 - $184,015
379 Added 58.31%
1,029 $486,000
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $127,199 - $139,176
-312 Reduced 32.43%
650 $271,000
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $329,966 - $395,074
962 New
962 $394,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Morningstar Investment Services LLC Portfolio

Follow Morningstar Investment Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morningstar Investment Services LLC with notifications on news.